Cubist Hits Hospira With Patent Suit Over Generic Cubicin
Cubist Pharmaceuticals Inc. lodged a suit against Hospira Inc. in Delaware federal court on Monday, claiming the generic-drug maker infringed a patent covering its drug Cubicin, an IV antibiotic used to...To view the full article, register now.
Already a subscriber? Click here to view full article